Leelamine (Synonyms: Dehydroabietylamine, NSC 2955) |
カタログ番号GC44048 |
リーラミンは、カンナビノイド受容体 CB1 および CB2 の弱いアゴニストです。リーラミンは、ピルビン酸脱水素酵素キナーゼ (PDK) も阻害します。リーラミンは抗腫瘍活性を示します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1446-61-3
Sample solution is provided at 25 µL, 10mM.
Leelamine is a diterpene molecule whose name derives from the Sanskrit word leela which means "play". It has weak affinity for the human central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, exhibiting 20% displacement of [3H]-CP55940 at a concentration of 10 µM. Leelamine inhibits pyruvate dehydrogenase kinase (PDK) with an IC50 value of 9.5 µM. Derivatives of leelamine exhibit anti-inflammatory activity and show moderate inhibition of phospholipase A2 activity from a variety of sources.
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *